Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: ``normal borrowing`` ...likely won`t occur here for years, I would think

RE: ``normal borrowing`` ...likely won`t occur here for years, I would think

posted on Mar 17, 2005 11:01AM
``even if they offered better deals to us, would they themselves be in a vulnerable position against Swartz because Swartz has a lock on the IP (and won`t let go),``

That being said....If TPL wanted to leverage..as they have some kind of assignment from iTv/Moore the same IP....where would their financier foothold be measured from ? Would their be any consideration on the financiers part...to check for prior incumbencies ?

I`m sure what ever arrangement they made with Moore...they can afford....and it will not be necessary for them to have to.

Would you give a note with or without stock issue to TPL utilizing the Moore/Fish IP as security...knowing that some where out there..some other company sits on it that may or may not be mightier than you ?

doni

Share
New Message
Please login to post a reply